By Deena Beasley (Reuters) -Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing ...
An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...
Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...
Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...
Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...
Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
Clinical Trials Arena on MSN2d
Ractigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancerThe company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...
In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...
The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 fatalities. But now, a new gene therapy is giving patients more hope of ...
News-Medical.Net on MSN2d
New insights into therapy resistance in breast cancerA new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback